Tempus AI:携手百时美施贵宝,后者将获准使用其Lens平台——一个以AI为核心、具备自主智能体能力的肿瘤药物研发平台

美股速递
Oct 23

Tempus AI:根据双方合作安排,百时美施贵宝将获得使用权,可接入Tempus AI旗下的Lens平台。该平台以人工智能为优先,是一个面向肿瘤药物开发的代理式平台。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10